Shanghai, China

Wan He

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 8.6

ph-index = 1


Company Filing History:


Years Active: 2021-2024

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Innovations in Oncology: The Patents of Wan He

Introduction: Wan He is a distinguished inventor based in Shanghai, China, with a focus on pharmaceutical innovations. With a total of three patents to his name, he has made significant contributions to the field, specifically in cancer treatment.

Latest Patents: Wan He's recent patents showcase his dedication to developing effective therapeutic solutions. His first patent involves a substituted heterocyclic fused cyclic compound, which is designed with a selective inhibitory effect on KRAS gene mutations. This compound holds promise in the preparation of cancer drugs alongside its pharmaceutical compositions.

Additionally, he has patented an aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative. This invention focuses on a compound substituted by N-(3-aminophenyl)acrylamide, which also has significant pharmaceutical implications for cancer treatment.

Career Highlights: Wan He has had an illustrious career, marked by his innovative research and development in the pharmaceutical industry. Notably, he has worked with prominent organizations such as Yangtze River Pharmaceutical Group Co., Ltd. and Shanghai Haiyan Pharmaceutical Technology Co., Ltd. His contributions in these roles have further solidified his reputation as a leading figure in drug development.

Collaborations: Throughout his career, Wan He has collaborated with talented individuals like Fusheng Zhou and Shuchun Guo. Their collective expertise has facilitated advancements in the pharmaceuticals they have worked on, contributing to significant innovations in cancer therapeutics.

Conclusion: Wan He's work exemplifies the spirit of innovation in the pharmaceutical sector. His inventions not only highlight his dedication to oncology but also improve the landscape of cancer treatment options available today. As he continues to develop groundbreaking technologies, the impact of his contributions in medicine is expected to resonate across industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…